PP
GILD icon

Postrock Partners’s Gilead Sciences GILD Stock Holding History

Postrock Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Hold
2,681
– – 0.14% 67
2026
Q1 		$374K Hold
2,681
– – 0.17% 64
2025
Q4 		$329K Hold
2,681
– – 0.14% 64
2025
Q3 		$298K Hold
2,681
– – 0.13% 69
2025
Q2 		$297K Hold
2,681
– – 0.14% 67
2025
Q1 		$300K Hold
2,681
– – 0.15% 64
2024
Q4 		$248K Buy
+2,681
New +$241K 0.12% 74

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Postrock Partners's GILD Position: Q2 2026 in Review

Postrock Partners held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,681 shares worth $339K. The position accounts for 0.14% of the portfolio, ranked #67.

Postrock Partners first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $374K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Postrock Partners held 2,681 shares of Gilead Sciences worth $339K as of Q2 2026.
  • Postrock Partners left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.14% of Postrock Partners's portfolio in Q2 2026, its #67 holding.
  • Postrock Partners first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Postrock Partners's Gilead Sciences position peaked at $374K in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Postrock Partners's 13F filing for Q2 2026, filed 24 Jul 2026.